Research Programs


Research Interests

Multiple sclerosis (MS), MRI biomarkers with clinical utility in prognostication and disease monitoring, cohort studies

Research Activities

Jiwon Oh is a staff neurologist, scientist, and Medical Director of the Barlo Multiple Sclerosis (MS) Program at St. Michael’s Hospital, University of Toronto. Dr. Oh’s research focuses on developing advanced MRI techniques in the spinal cord and brain for use in clinical settings. She leads the MRI research program at St. Michael’s Hospital, and is the principal investigator on numerous local and multi-center collaborative studies, including the Canadian Prospective Cohort Study to Understand Progression in MS (CanProCo), which is a national prospective cohort study designed to better understand progression in MS.

Recent Publications

  1. Oh, J, Bar-Or, A. Precision neuroimmunology in multiple sclerosis - the horizon is near. Nat Rev Neurol. 2024; :. doi: 10.1038/s41582-024-00992-6. PubMed PMID:38965380 .
  2. Lal, AP, Foong, YC, Sanfilippo, PG, Spelman, T, Rath, L, Levitz, D et al.. A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic. J Neurol. 2024; :. doi: 10.1007/s00415-024-12518-7. PubMed PMID:38935148 .
  3. Lim, TR, Suthiphosuwan, S, Micieli, J, Vosoughi, R, Schneider, R, Lin, AW et al.. Low-Field (64mT) Portable MRI for Rapid Point-of-Care Diagnosis of DIS in Patients Presenting with Optic Neuritis. AJNR Am J Neuroradiol. 2024; :. doi: 10.3174/ajnr.A8395. PubMed PMID:38926091 .
  4. Freedman, DE, Sawicka, KM, Oh, J, Main, E, Campbell, KA, Feinstein, A et al.. Clinical dimensions of people with co-occurring obsessive-compulsive and related disorders and multiple sclerosis: a scoping review protocol. BMJ Open. 2024;14 (5):e074929. doi: 10.1136/bmjopen-2023-074929. PubMed PMID:38816059 PubMed Central PMC11141195.
  5. Oh, J, Bhan, V, Traboulsee, A, Morrow, SA, Lee, L, Levin, M et al.. Health Canada drug approval process: a barrier to personalized care in multiple sclerosis. Can J Neurol Sci. 2024; :1-12. doi: 10.1017/cjn.2024.267. PubMed PMID:38777804 .
  6. Freedman, DE, Oh, J, Kiss, A, Puopolo, J, Wishart, M, Meza, C et al.. The influence of depression and anxiety on cognition in people with multiple sclerosis: a cross-sectional analysis. J Neurol. 2024; :. doi: 10.1007/s00415-024-12409-x. PubMed PMID:38730098 .
  7. Oh, J, Giacomini, PS, Yong, VW, Costello, F, Blanchette, F, Freedman, MS et al.. From progression to progress: The future of multiple sclerosis. J Cent Nerv Syst Dis. 2024;16 :11795735241249693. doi: 10.1177/11795735241249693. PubMed PMID:38711957 PubMed Central PMC11072059.
  8. Sharmin, S, Roos, I, Malpas, CB, Iaffaldano, P, Simone, M, Filippi, M et al.. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries. Lancet Child Adolesc Health. 2024;8 (5):348-357. doi: 10.1016/S2352-4642(24)00047-6. PubMed PMID:38547883 .
  9. Levit, E, Ren, Z, Gonzenbach, V, Azevedo, CJ, Calabresi, PA, Cree, BA et al.. Choroid plexus volume differentiates MS from its mimics. Mult Scler. 2024; :13524585241238094. doi: 10.1177/13524585241238094. PubMed PMID:38481081 .
  10. Lim, TRU, Kumaran, SP, Suthiphosuwan, S, Espiritu, AI, Jones, A, Lin, AW et al.. Limited utility of adding 3T cervical spinal cord MRI to monitor disease activity in multiple sclerosis. Mult Scler. 2024;30 (4-5):505-515. doi: 10.1177/13524585241228426. PubMed PMID:38419027 .
Search PubMed

Affiliations & Other Activities

  • Staff Neurologist, Division of Neurology, Department of Medicine, St. Michael’s Hospital
  • Associate Professor, Department of Medicine, University of Toronto
  • Adjunct Faculty, Department of Neurology, Johns Hopkins University